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Upon infection with Salmonella, a host develops an immune response to limit bacterial growth and kill and
eliminate the pathogen. Salmonella has evolved mechanisms to remain dormant within the body, only to
reappear (reactivate) at a later time when the immune system is abated. We have developed an in vivo model
for studying reactivation of Salmonella enterica serovar Typhimurium infection in mice. Upon subcutaneous
infection, C3H/HeN (Ityr) mice showed an increase in bacterial numbers in livers and spleens, which reached
a peak on day 19. After full recovery from the infection, these mice were irradiated or depleted of CD4 T cells.
The mice displayed a secondary infection peak in livers and spleens with a course similar to that of the primary
infection. We concluded that CD4 T cells are involved in active suppression of S. enterica serovar Typhi-
murium during latency. The role of CD4 T cells during primary infection with S. enterica serovar Typhi-
murium is well established. This is the first study to describe a role of CD4 T cells during the latent phase
of S. enterica serovar Typhimurium infection.
Salmonellae are gram-negative, facultative intracellular
pathogens that can cause a range of diseases in both animals
and humans that vary from mild diarrhea to severe infections
such as typhoid fever. It predominantly invades mononuclear
phagocytes, and despite antimicrobial mechanisms present in
phagocytic cells, Salmonella is able not only to enter but to
survive and even replicate within these cells. The bacterium
can cause chronic or persistent infection by evasion of the host
defense (13). This ability of Salmonella to replicate within
phagocytic cells is essential for its survival, as mutants unable
to do so are avirulent (5). Although the exact mechanisms for
intracellular survival of Salmonella after phagocytosis are still
uncertain, it is clear that Salmonella responds to the specific
host environment by expressing factors crucial for intracellular
survival (3, 6, 7, 13, 20).
Upon infection, the host mounts an immune response to
limit bacterial growth and to eventually kill and eliminate the
pathogen. B cells, T cells, and macrophages are important for
host resistance and their protective effects are mediated by
cytokines such as gamma interferon (IFN-), interleukin-12,
and tumor necrosis factor alpha (4, 14, 16–18, 23). This inte-
grated response results in activation of macrophages, which in
turn kill the Salmonella. Although the macrophages are the
main host cells, are necessary for survival and replication of
Salmonella within the host, and mediate the Salmonella-in-
duced pathology, macrophages also play a crucial role in host
defense against Salmonella (27). They are necessary for the
early local control of infection and, subsequently, for the in-
duction of acquired immunity (10, 15), as well as for restriction
of bacterial growth in immune mice (27).
Even in the presence of an acquired immune response, Sal-
monella has evolved mechanisms to persist within the body and
reappear (reactivate) at a later time. Several studies and case
reports have shown that patients who underwent total-body
irradiation or received an organ transplant and were treated
with glucocorticosteroids or other immunosuppressive drugs,
as well as patients suffering from human immunodeficiency
virus infection (11) or interleukin-12 receptor 1 deficiency
(24), can suffer from recurrent infections with a Salmonella
strain that persists within the host.
By investigating the possibility that S. enterica serovar Ty-
phimurium persists and reactivates after immune intervention
in a mouse model of latent S. enterica serovar Typhimurium
infection, we aimed to gain insight into the mechanisms by
which the host continually suppresses Salmonella from reacti-
vating at a later time.
MATERIALS AND METHODS
Mice. Six- to eight-week-old female Salmonella-resistant (Ityr) C3H/HeN mice
were obtained from Harlan (Horst, The Netherlands). Mice were maintained
according to institutional guidelines with water and food ad libitum in filter top
cages which were opened only inside a laminar flow cabinet. Studies were carried
out in accordance with and after approval of the animal research ethics com-
mittee of the Leiden University Medical Center.
Bacteria. For in vivo infection experiments S. enterica serovar Typhimurium
strain 14028s (50% lethal doses after intraperitoneal injection, 5  103 bacteria
for Ityr mice and 102 for Itys mice) was grown to the end of the log phase and
then washed and diluted in sterile phosphate-buffered saline (PBS). The number
of CFU in the inoculum was determined microbiologically.
Antibodies. Monoclonal antibodies (mAbs) directed to mouse T-cell surface
antigen CD4 were obtained from supernatant of cultured hybridoma GK1.5 (rat
anti-mouse CD4; American Type Culture Collection). The hybridoma was cul-
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FIG. 1. Bacterial loads within the lymph nodes (A), livers (B), and spleens (C) of mice infected with S. enterica serovar Typhimurium 14028s
that were irradiated on day 41 (■) and untreated infection controls (E) and bacterial loads within the lymph nodes (D), livers (E), and spleens
(F) of mice depleted of CD4 T cells (Œ) and infection controls (E). On days 39, 41, and 43 after infection, the mice were injected i.p. with 200
g, 100 g, and 100 g of rat anti-CD4 GK1.5 antibody, respectively. The infection controls were injected i.p. with an equal volume of PBS. At
different times, livers, spleens, and lymph nodes were aseptically removed, and cell lysates were made. The viable counts in the organs were
determined by plating serial dilutions of the cell lysates and are expressed as log10 viable counts (means  standard errors of the means). Data
from two independently performed experiments are shown. Asterisks indicate statistically significant differences compared to the infection controls
(one asterisk, P  0.05; two asterisks, P  0.005; Mann-Whitney rank order test), and the gray dashed lines indicate the detection limits of the
microbiological method (50 CFU for the livers and 30 CFU for the spleens and lymph nodes).
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tured in protein-free medium (Gibco), and supernatant was concentrated with a
capillary dialyzer, filter sterilized, and stored at 20°C. Fluorescein isothiocya-
nate-conjugated rat anti-mouse CD4 (L3T4) and phycoerythrin-conjugated rat
anti-mouse CD8 (Ly-2) monoclonal antibodies were obtained from BD Bio-
sciences.
S. enterica serovar Typhimurium infection. Mice were inoculated subcutane-
ously in the flanks with 0.1 ml of a bacterial suspension containing 3  104 CFU
of S. enterica serovar Typhimurium 14028s. For each group at each time three or
four mice were used. Mice were sacrificed by carbon dioxide inhalation, and
blood was taken by cardiac puncture. Spleens, livers, and inguinal lymph nodes
were removed, single-cell suspensions were prepared by using sterile 70-m-
mesh-size cell strainers (Falcon), and lysates were made. The number of bacteria
per organ was determined microbiologically by plating serial dilutions of the
lysates. The lowest numbers of bacteria that could be detected in this way were
30 CFU for the spleens and lymph nodes and 50 CFU for the livers.
Leukocyte count and blood cell differentiation. Leukocyte numbers were de-
termined by counting the number of nucleated cells in heparinized blood and by
making blood smears for the differentiation of the blood cells. Blood smears were
fixed in methanol and stained with Giemsa stain, and relative percentages of the
different types of blood cells were determined. By combining the data from
leukocyte counts and blood smears, we calculated the numbers of lymphocytes,
monocytes, and polymorphonuclear leukocytes present in the blood at the dif-
ferent times. The number of lymphocytes was used together with fluorescence-
activated cell sorter (FACS) analysis data to calculate the number of CD4 and
CD8 T cells.
Gamma irradiation and in vivo T-cell depletion. For total -body gamma
irradiation, mice were put in a small perspex box and were irradiated until a dose
of 6 Gy was reached. For depletion of CD4 T cells, mice were injected intra-
peritoneally (i.p.) with 200 g of rat anti-CD4 GK1.5 antibody. Mice received
second and third injections of 100 g of this antibody on days 2 and 4 after the
first injection. Infection controls were injected i.p. with an equal volume of PBS.
Flow cytometry. To determine CD4- and CD8-T-cell counts in blood, 100
l of heparinized blood was used. After the erythrocytes were lysed and washed
with PBS, the cells were labeled for 30 min with fluorescein isothiocyanate-
conjugated rat anti-mouse CD4 mAb and phycoerythrin-conjugated rat anti-
mouse CD8 mAb. Flow cytometry was performed with a FACSCaliber system
(Becton Dickinson).
Detection of S. enterica serovar Typhimurium-specific antibodies. Induction of
S. enterica serovar Typhimurium-specific antibodies was determined by a whole-
cell enzyme-linked immunosorbent assay (ELISA) (25). Maxisorp plates (Nunc)
were coated with S. enterica serovar Typhimurium 14028s, and serial dilutions of
the sera were added after nonspecific binding was blocked. Sera from naı¨ve mice
were included as a control. Wavelength absorbance was measured at 490 nm
using an ELISA plate reader (VICTOR2 1420 multilabel counter; Perkin-Elmer
Life and Analytical Sciences). The titer was defined as the dilution for which the
optical density at 450 (OD450) of the sample was more than the OD450 of the
naı¨ve serum plus 2 standard deviations.
Statistical analysis. For comparison between treatments we used Student’s t
tests for CD4- and CD8-T-cell counts and Mann-Whitney rank order tests for
CFU counts. For all analyses, a P value of 0.05 was considered significant.
RESULTS
Replication of S. enterica serovar Typhimurium 14028s dur-
ing a primary infection in C3H/HeN mice. Mice were inocu-
lated subcutaneously in the flanks with 3  104 CFU of S.
enterica serovar Typhimurium 14028s and showed an infection
comparable to that described previously (26). S. enterica sero-
var Typhimurium 14028s was detectable in the lymph nodes on
day 1 after infection; from there the infection spread to the
spleens and livers, and within these organs bacterial loads of up
to 3  107 CFU per organ were reached. The bacterial loads
were highest on day 19. The bacterial loads eventually de-
clined, which coincided with reductions in the spleen and liver
weights (data not shown).
Reactivation of the S. enterica serovar Typhimurium infec-
tion by gamma irradiation. On day 41, when the bacterial
loads in the organs were below the detection limit, the mice
received sublethal total-body irradiation (6 Gy). Infection con-
trols were not treated. The irradiated mice showed signs of
illness, like ruffled fur and malaise, between days 54 and 61.
The effects of the irradiation on the bacterial numbers in the
organs are shown in Fig. 1. In the infection control group, 60%
of the mice showed detectable amounts of bacteria in the livers
(Fig. 1B), but the averages were around or below the detection
limit and no increase in bacterial numbers could be observed.
The bacterial numbers in the lymph nodes and spleens stayed
below or around the detection limits (Fig. 1A and C). In the
irradiated mouse population, on the other hand, we observed
increases in the numbers of S. enterica serovar Typhimurium
cells in the livers and spleens (Fig. 1B and C) upon immune
intervention, and in all the mice the infection peaked on day
54. This secondary infection (i.e., reactivation) was milder than
the primary infection, as shown by the lower maximal bacterial
numbers in the organs reached, but otherwise it followed a
course that was similar to that of the primary infection peak
(Fig. 1). The irradiated mice showed reduced leukocyte counts
in the blood as soon as day 1 after the irradiation (day 42)
compared to the untreated infection controls, and the numbers
remained lower up to day 61 after infection (Table 1). Table 1
and Fig. 2A and B also show that the numbers of granulocytes
and CD4 and CD8 T cells declined in the irradiated mice.
These results suggest that the observed reactivation of the S.
enterica serovar Typhimurium infection upon irradiation could
have been due to the reduction in the numbers of either gran-
ulocytes, CD4 T lymphocytes, CD8 T lymphocytes, or a
combination of cells.
Reactivation following T-cell depletion. Reactivation of a
latent S. enterica serovar Typhimurium infection in people has
TABLE 1. Numbers of leukocytes, lymphocytes, monocytes, and
granulocytes in the blooda
Day Treatment
No. (105) of cells/ml
Leukocytes Lymphocytes Monocytes Granulocytes
1 None 54.7 8.3 38.7  12.9 1.1 0.5 14.3 8.9
5 None 85.1 13.5 48.3 9.4 1.8  1.4 29.9 7.3
12 None 77.3 24.4 30.4 12.7 0.8 0.7 42.3 13.6
19 None 100.7 28.5 33.8 13.8 2.8 2.2 52.2 13.1
26 None 78.0 13.4 39.3 5.6 1.2  1.0 33.8 11.7
33 None 110.8 37.6 52.2 10.3 1.8 1.9 53.3 29.2
42 None 86.2 29.7 53.7 18.0 0.7 0.7 27.9 14.2
irrb 23.5  9.4 7.4  3.8 0.0  0.0 15.5 6.3
43 deplc 50.2  11.3 26.3 6.9 1.1  0.9 21.6 13.0
47 None 87.8 23.9 58.5 20.6 1.0 0.5 24.7 7.6
irr 9.1  4.4 5.1  2.6 0.2  0.2 3.1 2.3
depl 61.1  21.2 31.4 11.8 1.5 1.6 26.2 17.1
54 None 50.8 29.0 29.0 22.4 0.6 0.7 19.3 10.2
irr 10.6  5.1 5.8  3.0 0.1  0.1 2.8 3.4
depl 89.6  21.1 39.0 16.2 2.1 1.4 39.0 16.2
61 None 94.6 24.1 45.6 14.3 1.0 1.1 41.9 27.4
irr 29.5  7.6 8.7  2.2 0.2  0.2 15.8 4.5
depl 55.0  14.2 29.2 8.5 0.7  0.4 23.2 11.9
a Values are means  standard deviations.
b irr, mice received total-body irradiation (6 Gy).
c depl, mice were depleted of CD4 T cells by injection of anti-CD4 antibod-
ies.
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been described for patients suffering from AIDS. This strongly
suggests a role for the CD4 T cells in the suppression of S.
enterica serovar Typhimurium during the persistence phase.
Since the irradiated mice also showed a reduction in granulo-
cytes and CD8 T cells, we wondered whether reducing the
number of CD4 T cells alone by in vivo depletion could also
result in the reactivation of a latent S. enterica serovar Typhi-
murium infection in C3H/HeN mice. In the infection control
group we observed no reactivation of the infection, as the
bacterial numbers stayed around or below the detection limits
in all the organs up to day 61. In the lymph nodes of the mice
that were depleted of CD4 T cells, we observed no detectable
outgrowth of S. enterica serovar Typhimurium (Fig. 1D). In the
livers and spleens, on the other hand, we observed increases in
bacterial numbers that were significantly different from those
in the infection controls, and the reactivation reached a peak
on day 47 (Fig. 1E and F). As observed for the irradiated mice,
this reactivation peak was lower than the peak observed for the
primary infection, but it followed a course that was similar to
that of the primary infection. FACS analysis of the lymphocyte
population revealed a strong decrease in the number of CD4
T cells in the depleted mice, indicating that the injection of the
rat-anti CD4 antibody resulted in successful depletion of the
CD4-T-cell population (Fig. 2C) and, as expected, had little
effect on the number of CD8 T cells (Fig. 2D).
Anti-Salmonella immunoglobulin G (IgG) antibodies in the
serum of S. enterica serovar Typhimurium-infected mice. To
determine whether the mice had antibodies to the pathogen,
serum was collected from the mice that were sacrificed at each
time, and anti-Salmonella IgG antibodies were detected using
a whole-cell ELISA. The infected mice started to produce
antibodies to S. enterica serovar Typhimurium 14028s between
days 5 and 12, when the infection reached its peak in the lymph
nodes and spleens. The titers increased further until day 43
after infection and then remained around a log3 dilution factor
of 8.5 (Fig. 3). The mice that were irradiated or depleted of
CD4 T cells and that showed reactivation of the S. enterica
serovar Typhimurium infection had serum antibody levels that
were similar to those of the infection controls. Thus, despite
the fact that these mice had serum antibodies to S. enterica
serovar Typhimurium, they still showed reactivation of the S.
enterica serovar Typhimurium infection.
DISCUSSION
The main finding of the present study of reactivation of
Salmonella after clearance of a primary systemic infection in
C3H/HeN (Ityr) mice is that after total-body irradiation or
selective CD4-T-cell depletion, the numbers of bacteria in
livers and spleens increased at a rate identical to that in the
FIG. 2. Numbers of CD4 T cells (A and C) and CD8 T cells (B and D) per ml of blood of C3H/HeN control mice infected with S. enterica
serovar Typhimurium (open bars), mice that received total-body irradiation (cross-hatched bars), and mice that were depleted of CD4 T cells
(solid bars). The numbers of CD4 and CD8 T cells were calculated by combining data from leukocyte counts, cell differentiation analysis, and
FACS analysis. Two asterisks indicate that the P value is 0.005, and one asterisk indicates that the P value is 0.05.
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primary infection. The only difference between the outgrowth
curves was that upon reactivation, S. enterica serovar Typhi-
murium infection was controlled more rapidly than it was in
the primary infection (i.e., by about 2 instead of 3 weeks). The
presence of Salmonella-specific antibodies did not prevent re-
activation but may help explain the difference in outgrowth
rates between irradiated and CD4-T-cell-depleted mice,
since antibodies act as opsonins for uptake by granulocytes
which are not affected by CD4-T-cell depletion.
We used subcutaneous S. enterica serovar Typhimurium in-
fection of C3H/HeN (Ityr) mice in the inguinal region to set up
a model for reactivation of S. enterica serovar Typhimurium
infection. By infecting subcutaneously, a reservoir is estab-
lished near draining lymph nodes, from which Salmonella
spreads via the lymph and becomes systemic, reaching the liver
and spleen (2). This model gives rise to a more subtle infection
than the intraperitoneal or intravenous models that result in
peracute and overwhelming infections. An advantage over oral
infection is that subcutaneously injected bacteria can be dosed
precisely, while in an oral infection the actual dose depends on
the number of bacteria that pass through the stomach and
cross the intestinal mucosa. Using subcutaneous infection, we
set up a new in vivo model for reactivation of latent S. enterica
serovar Typhimurium infection, in which total-body irradiation
or in vivo depletion of CD4 T cells in C3H/HeN (Ityr) mice
that had fully recovered from a primary infection with S. en-
terica serovar Typhimurium resulted in outgrowth of bacteria
that persisted within the body. In our reactivation model we
accepted that some of the control mice still showed some low
number of bacteria in the organs, just above the limit of de-
tection. Otherwise, we would have needed many more animals
to find only a few in which S. enterica serovar Typhimurium
persisted and reactivated upon irradiation or T-cell depletion.
Reactivation of a latent S. enterica serovar Typhimurium
infection in humans has been described in human immunode-
ficiency virus/AIDS patients (9), which (1, 8, 12) suggests a role
for CD4 T cells in the suppression of S. enterica serovar
Typhimurium during persistence. This is supported by a study
of Hung et al. in Taiwan showing that the risk of recurrent
nontyphoidal Salmonella bacteremia decreased dramatically
after the introduction of highly active antiretroviral therapy
and coincides with recovery of CD4-T-cell counts and recon-
stitution of immunity (11).
We investigated whether reducing the number of CD4 T
cells could result in reactivation of a (latent) S. enterica serovar
Typhimurium infection. Like irradiated mice, CD4-T-cell-
depleted mice showed reactivation of S. enterica serovar Ty-
phimurium infection in both livers and spleens. This reactiva-
tion occurred despite the presence of high titers of anti-S.
enterica serovar Typhimurium antibodies (Fig. 3). This is con-
sistent with the observation that protection against Salmonella
requires both immune serum and T cells (19).
Recently, Monack et al. described a model for chronic car-
riage of S. enterica serovar Typhimurium in Ityr mice (21). In
contrast to our latent infection model in which bacteria could
no longer be detected in the lymph nodes after 43 days, these
mice showed high numbers of bacteria in the mesenteric lymph
nodes up until 268 days after oral infection and periodic fecal
shedding, as observed for chronic carriers of S. enterica serovar
Typhi and S. enterica serovar Paratyphi in humans. Monack et
al. showed that IFN- plays an essential role in the control of
chronically persistent S. enterica serovar Typhimurium infec-
tion, since neutralization resulted in reactivation (21). Neutral-
ization of IFN- precludes activation of infected macrophages
by all types of IFN--producing cells and results in reactivation
of S. enterica serovar Typhimurium infection. In our reactiva-
tion model of latent infection, however, we depleted mice of
CD4 T cells, precluding the production of IFN- by this type
of cell, but the IFN--producing NK and CD8 T cells were
still present (Fig. 2D). Apparently, the amounts of IFN- pro-
duced by these cells are not sufficient to appropriately activate
macrophages and prevent reactivation. Our data, together with
those described by Monack et al., indicate that IFN- pro-
duced by CD4 T cells is necessary to suppress bacterial
growth during the persistence phase and suggest that IFN-
produced by NK cells and CD8 T cells does not play a pivotal
role in this respect.
It is generally accepted that CD4 T cells play an important
role in the clearance of bacteria during a primary infection with
S. enterica serovar Typhimurium. Mice depleted of CD4 T
cells on the day of infection are highly susceptible to S. enterica
serovar Typhimurium and rapidly die due to the lack of CD4-
T-cell-mediated defense against Salmonella (22). Our study is
the first study that describes a role of CD4 T cells in prevent-
ing reactivation of S. enterica serovar Typhimurium infection in
Ityr mice during the persistence phase. The in vivo reactivation
mouse model is suitable for further studies on reactivating S.
enterica serovar Typhimurium infections and might provide
insight into bacterial strategies that S. enterica serovar Typhi-
murium uses to persist in its host. Detailed knowledge of these
mechanisms is necessary to develop new approaches for pre-
venting relapsing infections with salmonellae in immunocom-
promised hosts.
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